Center for Research in Reproduction and Contraception, Seattle, WA, USA; Diabetes Institute, Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Diabetes Institute, Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
J Clin Lipidol. 2018 Jul-Aug;12(4):1072-1082. doi: 10.1016/j.jacl.2018.04.013. Epub 2018 Apr 30.
Exogenous testosterone decreases serum concentrations of high-density lipoprotein cholesterol (HDL-C) in men, but whether this alters cardiovascular risk is uncertain.
To investigate the effects of testosterone and estradiol on HDL particle concentration (HDL-Pima) and metrics of HDL function.
We enrolled 53 healthy men, 19 to 55 years of age, in a double-blinded, placebo-controlled, randomized trial. Subjects were rendered medically castrate using the GnRH receptor antagonist acyline and administered either (1) placebo gel, (2) low-dose transdermal testosterone gel (1.62%, 1.25 g), (3) full replacement dose testosterone gel (1.62%, 5 g) or (4) full replacement dose testosterone gel together with an aromatase inhibitor for 4 weeks. At baseline and end of treatment, serum HDL total macrophage and ABCA1-specific cholesterol efflux capacity (CEC), HDL-Pima and size, and HDL protein composition were determined.
Significant differences in serum HDL-C were observed with treatment across groups (P = .01 in overall repeated measures ANOVA), with increases in HDL-C seen after both complete and partial testosterone deprivation. Medical castration increased total HDL-Pima (median [interquartile range] 19.1 [1.8] nmol/L at baseline vs 21.3 [3.1] nmol/L at week 4, P = .006). However, corresponding changes in total macrophage CEC and ABCA1-specific CEC were not observed. Change in serum 17β-estradiol concentration correlated with change in total macrophage CEC (β = 0.33 per 10 pg/mL change in serum 17β-estradiol, P = .03).
Testosterone deprivation in healthy men leads to a dissociation between changes in serum HDL-C and HDL CEC. Changes in serum HDL-C specifically due to testosterone exposure may not reflect changes in HDL function.
外源性睾酮会降低男性血清高密度脂蛋白胆固醇(HDL-C)浓度,但这是否会改变心血管风险尚不确定。
研究睾酮和雌二醇对 HDL 颗粒浓度(HDL-Pima)和 HDL 功能指标的影响。
我们招募了 53 名年龄在 19 至 55 岁之间的健康男性,进行了一项双盲、安慰剂对照、随机试验。受试者使用 GnRH 受体拮抗剂 acyline 进行医学去势,并接受以下治疗:(1)安慰剂凝胶,(2)低剂量经皮睾酮凝胶(1.62%,1.25 g),(3)全替代剂量睾酮凝胶(1.62%,5 g)或(4)全替代剂量睾酮凝胶联合芳香酶抑制剂治疗 4 周。在基线和治疗结束时,测定血清 HDL 总巨噬细胞和 ABCA1 特异性胆固醇流出能力(CEC)、HDL-Pima 和大小以及 HDL 蛋白组成。
治疗组之间的血清 HDL-C 存在显著差异(整体重复测量方差分析 P = 0.01),完全和部分去势后 HDL-C 均增加。医学去势增加了总 HDL-Pima(中位数[四分位距],基线时为 19.1[1.8]nmol/L,第 4 周时为 21.3[3.1]nmol/L,P = 0.006)。然而,总巨噬细胞 CEC 和 ABCA1 特异性 CEC 没有相应的变化。血清 17β-雌二醇浓度的变化与总巨噬细胞 CEC 的变化相关(血清 17β-雌二醇每变化 10 pg/mL,β = 0.33,P = 0.03)。
健康男性的睾酮剥夺导致血清 HDL-C 和 HDL CEC 的变化脱钩。由于睾酮暴露而导致的血清 HDL-C 的变化可能并不反映 HDL 功能的变化。